AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
Treatment resulted in lower HF hospitalization rate in patients with, without atherosclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Treatment resulted in lower HF hospitalization rate in patients with, without atherosclerosis
Only registered members have full access to PracticeUpdate content.